When the medication is discontinued right after attaining fat reduction, a possibility of rebound bodyweight gain exists. This was demonstrated within an extension from the Move 1 demo, in which participants, immediately after discontinuing weekly subcutaneous semaglutide 2. When success from LEADER, SUSTAIN-six, Harmony Results, REWIND, and AMPLITUDE-O have demonstrated https://semaglutide76421.blogoscience.com/36730447/not-known-factual-statements-about-semaglutide